Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00643942 · ClinicalTrials.gov registry record
Staining in a Healthy, Non-Dry Eye Population
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 120
- Enrollment target
NCT00643942: Completed study, sponsored by Alcon Research.
NCT00643942 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00643942 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The clinical objective of this study is to quantify the levels of corneal and conjunctival staining in a healthy, non-dry eye population. This is a descriptive study without test article administered.
Interventions
- OTHER No intervention required
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2007-06 |
What the finished NCT00643942 record still lists
NCT00643942 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention required is the first listed.
NCT00643942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00643942 about?
NCT00643942 is a clinical study titled "Staining in a Healthy, Non-Dry Eye Population". The clinical objective of this study is to quantify the levels of corneal and conjunctival staining in a healthy, non-dry eye population. This is a descriptive study without test article administered.
What is the current status of trial NCT00643942?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2007-06.
What interventions are being tested in trial NCT00643942?
The interventions under investigation include: No intervention required (OTHER).
Who is sponsoring clinical trial NCT00643942?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia